Hospital Virgen del Mar

Almería 04120

0 studies enrolling now · 6 studies all time

What they study most

Cancer, Cardiovascular Disease, Covid19, Diabetes Mellitus, Type 2, Dyslipidemia, Pain, Palliative Care, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. — Completed